Results 221 to 230 of about 1,021,105 (352)

Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency [PDF]

open access: bronze, 2020
Craig D. Platt   +8 more
openalex   +1 more source

Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study

open access: yesThe Lancet, 2019
J. Lord   +107 more
semanticscholar   +1 more source

The role of Rho GTPases in facial morphogenesis

open access: yesDevelopmental Dynamics, EarlyView.
The role of small GTPases, RHOA, RAC1, and CDC42 and pathway mediators is reviewed in the context of embryonic facial development. Lip fusion requires cytoskeletal remodeling during morphogenesis of the facial processes and during lip fusion. Fnm, frontonasal mass; lnp, lateral nasal process; mnp, medial nasal process; mxp, maxillary process; np, nasal
Isra Ibrahim, Joy M. Richman
wiley   +1 more source

Detection of Chromosomal Aneuploidy Using Exome Sequencing. [PDF]

open access: yesGenes (Basel)
Al-Hamed MH   +9 more
europepmc   +1 more source

MOESM1 of Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients

open access: gold, 2019
Amanda Johansen   +8 more
openalex   +1 more source

Whole‐exome sequencing for variant discovery in blepharospasm [PDF]

open access: gold, 2018
Jun Tian   +14 more
openalex   +1 more source

Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus

open access: yesNature Medicine, 2020
S. Jin   +60 more
semanticscholar   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

Whole-exome sequencing in pediatric patients with glomerulonephritis. [PDF]

open access: yesFront Genet
Peric M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy